论文部分内容阅读
慢性阻塞性肺疾病 (COPD或GOLD)是困扰人类的不易根治的慢性呼吸系统疾病 ,自 2 0世纪50年代即备受医学界有关专家的观注 ,并从流行病学调查到临床的诊断治疗做了大量的研究工作。随着老龄化社会的到来 ,COPD的患病率以及病死率成为全球性的问题。本文选译自《最新医学》杂志 2 0 0 2年第 57卷第 1 0期特集“日本の慢性闭塞性肺疾患 (COPD)の现状とGOLDのインパクト” ,就日本COPD的研究状况及其防治创议 (GOLD)做详尽阐述 ,内容全面、新颖 ,颇具参考价值。本专辑由大连医科大学第一附属医院ICU万献尧、毕丽岩教授主译、主审。
Chronic Obstructive Pulmonary Disease (COPD or GOLD) is a chronic, non-curable, chronic respiratory disease that has plagued humans. It has been the subject of medical experts’ attention since the 1950s and has gone from epidemiological investigation to clinical diagnosis and treatment Done a lot of research work. With the advent of an aging society, the prevalence of COPD and mortality have become global issues. This article is translated from the latest Medical Magazine Vol. 57 No. 1 Vol. 02 issue of “Japan’s chronic obstructive pulmonary disease (COPD) status quo and GOLD の イ ン パ ク Suites” on the Japanese study of COPD and its prevention and treatment Creative (GOLD) to elaborate, the contents of a comprehensive, innovative, quite a reference value. The album by the First Affiliated Hospital of Dalian Medical University Wan Xiangyao, Professor Bi Liyan main translation, the trial.